Literature DB >> 30706765

Testicular metastasis from renal cell carcinoma after nephrectomy and on tyrosine kinase inhibitors therapy: Case report and review.

Alberto De Gobbi1, Mario Salvatore Mangano1, Giandavide Cova1, Claudio Lamon1, Luigino Maccatrozzo1.   

Abstract

Renal cell carcinoma has extremely heterogeneous presentation at the diagnosis: it may present as a confined organ disease, locally advanced, metastatic to locoregional lymph nodes or with single or multiple systemic metastases. Since chemotherapy and radiation therapy have not demonstrated efficacy either in primary therapy or in neo-adjuvant or adjuvant therapy for renal clear cell carcinoma, targeted agents like tirosine kinase inhibitors were developed and are largely used in locally advanced and metastatic renal cell carcinoma. Here, we present a rare case of ipsilateral renal cell carcinoma testicle metastasis, after radical nephrectomy and during tyrosine kinase inhibitors therapy. In addition, a retrospective search in PubMed, ScienceDirect, and Web of Science database on testicular metasteses from renal cell carcinoma under tyrosine kinase inhibitors therapy was performed.

Entities:  

Keywords:  RCC; Renal cell carcinoma; TKI; testicular metastases; tyrosine kinase inhibitor

Mesh:

Substances:

Year:  2019        PMID: 30706765     DOI: 10.1177/0391560318818951

Source DB:  PubMed          Journal:  Urologia        ISSN: 0391-5603


  2 in total

1.  RB1CC1 functions as a tumor-suppressing gene in renal cell carcinoma via suppression of PYK2 activity and disruption of TAZ-mediated PDL1 transcription activation.

Authors:  Pingfeng Chen; Youjun Duan; Xinsheng Lu; Libo Chen; Wang Zhang; Hao Wang; Rong Hu; Shimin Liu
Journal:  Cancer Immunol Immunother       Date:  2021-04-10       Impact factor: 6.968

2.  Renal Cell Carcinoma with Testicular Metastases: A Case Report and Review of the Literature.

Authors:  Sho Yoshitake; Brian M Shinder; Kevin Dazen; Colton Smith; Tina M Mayer; Evita Sadimin; Eric A Singer
Journal:  J Kidney Cancer VHL       Date:  2022-05-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.